{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:37:11Z","timestamp":1792827431568,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.nbd.2026.107653","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:16:58Z","timestamp":1791991018000},"page":"107653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment-refractory autoimmune glial fibrillary acidic protein astrocytopathy: Clinical features, predictive models, therapy"],"prefix":"10.1016","volume":"231","author":[{"given":"Shifeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayang","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107653_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107653_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101924","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy resulting in treatment-refractory flaccid paralysis","volume":"39","author":"Allen","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107653_bb0015","series-title":"Autoimmune Encephalitis","article-title":"Disclosure: Chichun E Sun declares no relevant financial relationships with ineligible companies","author":"Anand","year":"2026"},{"key":"10.1016\/j.nbd.2026.107653_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12028-024-01998-0","article-title":"Acute-phase Neurofilament light and glial fibrillary acidic proteins in cerebrospinal fluid predict Long-term outcome after severe traumatic brain injury","volume":"41","author":"Andersson","year":"2024","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.nbd.2026.107653_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-025-13159-0","article-title":"Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy","volume":"272","author":"Arzalluz-Luque","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/1756286421998906","article-title":"Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression","volume":"14","author":"Banks","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.nbd.2026.107653_bb0035","article-title":"Case report: ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy","volume":"14","author":"Cao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1695461","article-title":"Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107009","article-title":"Evaluation of blood-brain barrier integrity and clinical characteristics in autoimmune glial fibrillary acidic protein astrocytopathy","volume":"107","author":"Chen","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107653_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0055","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40263-022-00943-z","article-title":"Treatment options in refractory autoimmune encephalitis","volume":"36","author":"Dinoto","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2026.107653_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1265609","article-title":"Plasma exchange for two patients with autoimmune GFAP astrocytopathy with rapid progression to respiratory failure: a case report","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1\u00a0year","volume":"321","author":"Dubey","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/332738a0","article-title":"The binding site for C1q on IgG","volume":"332","author":"Duncan","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107653_bb0075","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein Astrocytopathy: a novel Meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.nbd.2026.107653_bb0085","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107653_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-023-02678-7","article-title":"New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis","volume":"147","author":"Guo","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107653_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16284","article-title":"Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: a systematic review and meta-analysis","volume":"31","author":"Hagbohm","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0100","first-page":"1","article-title":"Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults","author":"Hahn","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107653_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70489","article-title":"Investigation of prognostic factors in patients with autoimmune glial fibrillary acidic protein astrocytopathy","volume":"33","author":"Kimura","year":"2026","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578458","article-title":"Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: a case series","volume":"396","author":"Lai","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa137","article-title":"Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury","volume":"2","author":"Laverse","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.nbd.2026.107653_bb0120","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/acn3.51540","article-title":"The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis","volume":"9","author":"Lee","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107142","article-title":"Single-institution experience with efgartigimod in patients with GFAP astrocytopathy: treatment response and adverse events","volume":"109","author":"Li","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.nbd.2026.107653_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70042","article-title":"Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: retrospective research of clinical practice, biomarkers, and pathology","volume":"30","author":"Lin","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2026.107653_bb0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ene.13531","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study","volume":"25","author":"Long","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0140","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.181.9.6417","article-title":"Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis","volume":"181","author":"Marques","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1167\/iovs.13-11821","article-title":"Fcgamma receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration","volume":"55","author":"Murinello","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.nbd.2026.107653_bb0150","article-title":"Tau, glial fibrillary acidic protein, and Neurofilament light chain as brain protein biomarkers in cerebrospinal fluid and blood for diagnosis of neurobiological diseases","volume":"25","author":"Park","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107653_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000514547","article-title":"Protein a Immunoadsorption relieves autoimmune glial fibrillary acidic protein Astrocytopathy after unsuccessful methylprednisolone treatment","volume":"28","author":"Qin","year":"2021","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.nbd.2026.107653_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107653_bb0165","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.4049\/jimmunol.1302911","article-title":"Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells","volume":"192","author":"Sasaki","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0170","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/acn3.52305","article-title":"CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity","volume":"12","author":"Segal","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-012-0995-3","article-title":"Intracerebral immune complex formation induces inflammation in the brain that depends on fc receptor interaction","volume":"124","author":"Teeling","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107653_bb0180","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1007\/s00415-023-11908-7","article-title":"Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease","volume":"270","author":"Theuriet","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0190","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0195","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0200","doi-asserted-by":"crossref","first-page":"11511","DOI":"10.1523\/JNEUROSCI.1514-09.2009","article-title":"Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS","volume":"29","author":"Voskuhl","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107653_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.779","article-title":"Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: case report and systematic literature review","volume":"7","author":"Wei","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.nbd.2026.107653_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-016-0485-y","article-title":"Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain","volume":"13","author":"Wu","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2026.107653_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577718","article-title":"Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: a pooled analysis of 324 cases from published data and a single-center retrospective study","volume":"360","author":"Xiao","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0220","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s10072-024-07843-8","article-title":"Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review","volume":"46","author":"Xu","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107653_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790962","article-title":"Immunotherapy for refractory autoimmune encephalitis","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2026.107653_bb0230","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/ene.14778","article-title":"CD8(+) T-cell predominance in autoimmune glial fibrillary acidic protein astrocytopathy","volume":"28","author":"Yuan","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107653_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70102","article-title":"A comparative study of 141 glial fibrillary acidic protein immunoglobulin G positive cases","volume":"32","author":"Zhang","year":"2025","journal-title":"Eur. J. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126003992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126003992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:52:07Z","timestamp":1792824727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126003992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"alternative-id":["S0969996126003992"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107653","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment-refractory autoimmune glial fibrillary acidic protein astrocytopathy: Clinical features, predictive models, therapy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107653"}}